Verastem, Inc.
VSTM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001526119
In the last 90 days, Verastem, Inc. insiders filed 0 open-market purchases and 2 sales; 156 institutions reported holding it in 13F filings for Q2 2026, worth $363.5M in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding Verastem, Inc. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Of which not filed for Q3 2025 | Q3 2025 | Change |
|---|---|---|---|---|
| Holders | 111 | 1 | 118 | +8 |
| Shares | 52.6M | 11.7K | 59.6M | +7.06M (+13.4%) |
| Value | $218.3M | $48.6K | $526.5M | +$308.2M (+141.3%) |
1 institution that held it in Q2 2025 haven't filed for Q3 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (28)
Institutions that held Verastem, Inc. at the end of Q3 2025 but not at the end of Q2 2025.
Sold out (20)
Institutions that held Verastem, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| BVF Inc | 3,404,425 | $14.1M |
| AIGH Capital Management LLC | 2,003,179 | $8.31M |
| Nomura Holdings Inc | 674,596 | $2.80M |
| Exome Asset Management LLC | 599,900 | $2.49M |
| Qube Research & Technologies Ltd | 282,228 | $1.17M |
| UBS Oconnor LLC | 255,253 | $1.06M |
| Prelude Capital Management, LLC | 180,400 | $748.7K |
| Alyeska Investment Group, L.P. | 131,770 | $546.8K |
| Renaissance Technologies LLC | 98,600 | $409.2K |
| Kennedy Capital Management, Inc. | 90,203 | $374.3K |
| Susquehanna Portfolio Strategies, LLC | 58,521 | $242.9K |
| Virtu Financial LLC | 53,403 | $222.0K |
| Los Angeles Capital Management LLC | 25,428 | $105.5K |
| Graham Capital Management, L.P. | 16,361 | $67.9K |
| Voya Investment Management LLC | 12,758 | $52.9K |
| Nebula Research & Development LLC | 12,689 | $52.7K |
| Accent Capital Management, LLC | 52 | $5.25K |
| Caitong International Asset Management Co., Ltd | 814 | $3.38K |
| National Bank of Canada | 37 | $154 |
| US Bancorp | 23 | $95 |
Not filed for Q3 2025 yet (1)
Institutions that held Verastem, Inc. at the end of Q2 2025 and haven't filed a 13F for Q3 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| E Fund Management Co., Ltd. | 11,700 | $48.6K |